Cardiometabolic
The App Wasn’t Enough: Nurse-Led Digital Diabetes Care Linked to Better HbA1c and Adherence
A real-world study in type 2 diabetes found substantially higher digital engagement and greater HbA1c reductions when a diabetes app was embedded in structured nurse-led monitoring, education and escalation. The findings challenge a persistent assumption in digital health: deploying technology is not the same as implementing care.
As GLP-1 use expands, healthcare systems are confronting a new challenge: balancing obesity treatment with rising concerns about eating disorders and patient safety.
A new guideline is changing how health systems think about obesity, diabetes and heart disease
The next cardiometabolic battleground is ultra-processed food
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Physical activity continues to strengthen its case as a cross-disease prevention strategy
Can cortisol become the next target in type 2 diabetes?
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Europe’s Safe Hearts Plan Makes Prevention a Political Test
AI Diabetes Tools Need Infrastructure Before Scale
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Cardiometabolic
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases